tiprankstipranks
Advertisement
Advertisement

Predict shareholders approve 2025 results and renew treasury share buyback mandate

Story Highlights
  • Predict posted higher 2025 revenues but weaker margins, missed its EBITDA target, and will cancel a tranche of price adjustment shares without altering share capital.
  • Shareholders renewed a treasury share buyback of up to €700,000 and 20% of capital to support liquidity, incentive plans and future strategic transactions on Euronext Growth Milan.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Predict shareholders approve 2025 results and renew treasury share buyback mandate

Claim 55% Off TipRanks

The latest announcement is out from Predict S.P.A. Class B ( (IT:PRE) ).

Predict S.p.A.’s shareholders approved the 2025 financial statements, confirming revenue growth to €7.60 million but a decline in profitability, with EBITDA, EBIT and net profit all lower than in 2024 and a weakening yet still cash‑positive net financial position. The company will allocate its €170,526.85 net profit to the legal reserve and retained earnings, and the failure to meet its €1 million EBITDA target triggers the cancellation, without impact on share capital, of the second tranche of 90,000 price adjustment shares held by reference shareholder Qo3 S.r.l.

The meeting also renewed authorization for the board to buy and sell treasury shares for up to €700,000 and up to 20% of share capital over the next 18 months, under strict price and volume limits aligned with EU market abuse rules. This buyback flexibility is intended to support share liquidity, underpin share‑based incentive plans and provide stock as potential consideration in future extraordinary transactions, enhancing Predict’s financial and strategic toolkit in the Euronext Growth Milan market.

The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.40 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.

More about Predict S.P.A. Class B

Predict S.p.A. is an Italian innovative SME in the med‑tech sector focused on in vivo diagnostics, distributing ultrasound and radiology equipment and developing technologies for breath analysis and digital healthcare. The company operates through several business units, including Imaging, People Support, Mistral and Digital Healthcare, targeting hospital and healthcare markets with both hardware and digital solutions.

Average Trading Volume: 24,658

Technical Sentiment Signal: Sell

Current Market Cap: €5.64M

For an in-depth examination of PRE stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1